Net revenues rose 52.2 per cent to $1,404,000, driven by strong VIVID product demand within the Torbal Division...
Only 0.5% of multilateral climate finance goes to health, despite climate change projected to cause up to 15.6 millions deaths by 2050....
Through this expansion, laboratories will have direct access to Colaborate's consulting expertise, combined with the reliability and reach of Henry Schein's network and lab capabilities...
The ProVee System uses a nitinol stent designed to gently reshape the enlarged BPH prostate and alleviate the associated lower urinary tract symptoms...
Kangji Medical Holdings Limited and Knight Bidco Limited today jointly announced the pre-conditional proposal for the privatisation of Kangji Medical Holdings Limited by way of a scheme of arrangement (the “Proposal”). Proposed privatisation of Kangji Medical Holdings Limited The Cancellation Price of HK$9.25 per share represents a 21.7% premium over the closing price on 30 June, 2025, being the Undisturbed Date, a 47.3% premium over the 360-trading day average closing price up to and incl...
Diagnostic imaging leads revenue surge; Novena centre expands reach in preventive healthcare ...
Funding boost to support pivotal trial and pre-commercialization of CLAAS® AcuFORM™ LAAO system. ...
With total federal support exceeding $52M, RIVANNA accelerates development of CADe/x — an AI-driven diagnostic tool poised to transform musculoskeletal care through automated ultrasound image analysis and real-time fracture triage. ...
New Metrix Filovirus Panel to deliver 30-minute, lab-quality results from blood samples in remote and point-of-care settings—marking a pivotal step in global outbreak preparedness. ...
Collaboration aims to develop next-generation endoluminal robotic platforms for enhanced precision and minimally invasive interventions in gastrointestinal care....
